[1]
I. S. Mykhaloiko, R. I. Yatsyshyn, I. O. Dudar, O. I. Hotsaniuk, and H. M. Kuryliv, “Safety and efficacy of apixaban in patients with glomerulonephritis and nephrotic syndrome: a prospective longitudinal cohort study”, Modern Medical Technology, vol. 17, no. 1, pp. 41–45, Mar. 2025.